Fund moves

Merck (MRK): Bridgewater Associates added to its stake +9,039 shares

Bridgewater Associates added to its stake in Merck, per its Q3 2026 13F.

39K
Shares reported · +9,039 vs prior quarter
0.02%
Disclosed portfolio weight
$5.71M
Reported value
Holdings as of
Sep 30, 2026
Filed
Nov 16, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 14, 2026Federal contract · $1.6M obligatedDepartment of Health and Human Services awarded Merck: $1.63M obligated to date
  2. Sep 21, 2026FDAFDA drug approval: Winrevair
  3. Sep 24, 2026FDAFDA drug approval: Welireg
  4. Sep 24, 2026Federal contract · $21K obligatedDepartment of Veterans Affairs awarded Merck: $21K obligated to date
  5. Sep 24, 2026CongressDisclosed partial sale of MRK — reported range $1,001 - $15,000
  6. Oct 9, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“(d) Incorporated by reference is a press release issued by Merck & Co., Inc. (the “Company”) on October 13, 2026, attached as Exhibit 99.1, announcing the election of Paul J. Diaz to the Company’s Board of Directors (the “Board”), effective November 1, 2026.”
  7. Oct 14, 2026FDAFDA drug approval: Enflonsia
  8. Oct 16, 2026FDAFDA drug approval: Keytruda
  9. Oct 16, 2026FDAFDA drug approval: Keytruda Qlex
  10. Oct 29, 2026Company filing · Form 8-K · ResultsReported its results
  11. Nov 12, 2026InsiderOfficer sold ~$8.61M of MRK shares in the open market
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Merck

For Merck, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 3 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MRK page.

How this filing works

Explore the data

Common questions

What does this filing report about Merck (MRK) stock?

Bridgewater Associates added to its stake in Merck, per its Q3 2026 13F. Now 39K shares, $5.71M reported value, 0.02% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Sep 30, 2026. Filed: Nov 16, 2026.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Merck recently?

For Merck, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 3 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days. They are listed on the MRK page.

Does this mean MRK stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Merck

Everything OQRO holds on this company is on its MRK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data